STANDARDIZED UPTAKE VALUES OF NORMAL-TISSUES AT PET WITH 2-[FLUORINE-L8]-FLUORO-2-DEOXY-D-GLUCOSE - VARIATIONS WITH BODY-WEIGHT AND A METHOD FOR CORRECTION

被引:506
作者
ZASADNY, KR [1 ]
WAHL, RL [1 ]
机构
[1] UNIV MICHIGAN,MED CTR,DEPT INTERNAL MED,DIV NUCL MED,ANN ARBOR,MI 48109
关键词
BREAST; NEOPLASMS; BREAST NEOPLASMS; DIAGNOSIS; EMISSION CT;
D O I
10.1148/radiology.189.3.8234714
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
PURPOSE: To study the relationship between standardized uptake values (SUVs) in normal tissues and body weight determined with positron emission tomography (PET). MATERIALS AND METHODS: SUVs were determined in 28 nondiabetic women with newly diagnosed untreated primary breast cancers. Body weights ranged from 45 to 107 kg. SUVs for lung, liver, marrow, spleen, blood, and normal breast were determined from images obtained with PET 50-60 minutes after injection of 2-[fluorine-18]-fluoro-2-deoxy-D-glucose (FDG). RESULTS: There was a positive correlation between SUV and body weight for blood, (r = .75, P = .000004), liver (r = .72, P = .000081), and spleen (r = .57, P = .033), all of which had substantial F-18 activity. In heavy patients, SUVs fo r those normal tissues were up to twice those of lighter patients. Calculating SUV on the basis of predicted lean body mass (SUV-Lean) eliminated the weight dependence of the SUV for blood (r =.26, P =.18) and reduced weight dependence in other tissues. CONCLUSION: SUV-Lean is a weight-independent index for blood FDG accumulation at PET and may be more appropriate than SUV for quantifying F-18 activity in tumors.
引用
收藏
页码:847 / 850
页数:4
相关论文
共 28 条
[1]   GRADING LIPOSARCOMAS WITH PET USING [F-18] FDG [J].
ADLER, LP ;
BLAIR, HF ;
WILLIAMS, RP ;
PATHRIA, MN ;
MAKLEY, JT ;
JOYCE, MJ ;
ALKAISI, N ;
MIRALDI, F .
JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 1990, 14 (06) :960-962
[2]  
BAILET JW, 1992, LARYNGOSCOPE, V102, P281
[3]   GLUCOSE-UTILIZATION OF CEREBRAL GLIOMAS MEASURED BY [F-18] FLUORODEOXYGLUCOSE AND POSITRON EMISSION TOMOGRAPHY [J].
DICHIRO, G ;
DELAPAZ, RL ;
BROOKS, RA ;
SOKOLOFF, L ;
KORNBLITH, PL ;
SMITH, BH ;
PATRONAS, NJ ;
KUFTA, CV ;
KESSLER, RM ;
JOHNSTON, GS ;
MANNING, RG ;
WOLF, AP .
NEUROLOGY, 1982, 32 (12) :1323-1329
[4]   PET EVALUATION OF SOFT-TISSUE MASSES WITH F-18 FLUORO-2-DEOXY-D-GLUCOSE [J].
GRIFFETH, LK ;
DEHDASHTI, F ;
MCGUIRE, AH ;
MCGUIRE, DJ ;
PERRY, DJ ;
MOERLEIN, SM ;
SIEGEL, BA .
RADIOLOGY, 1992, 182 (01) :185-194
[5]  
HABERKORN U, 1991, J NUCL MED, V32, P1548
[6]   UPTAKE OF 2-DEOXY, 2-(18F) FLUORO-D-GLUCOSE IN BLADDER-CANCER - ANIMAL LOCALIZATION AND INITIAL PATIENT POSITRON EMISSION TOMOGRAPHY [J].
HARNEY, JV ;
WAHL, RL ;
LIEBERT, M ;
KUHL, DE ;
HUTCHINS, GD ;
WEDEMEYER, G ;
GROSSMAN, HB .
JOURNAL OF UROLOGY, 1991, 145 (02) :279-283
[7]  
KUBOTA K, 1985, J NUCL MED, V26, P37
[8]   HIGH [F-18]FDG UPTAKE IN PRIMARY CEREBRAL LYMPHOMA - A PET STUDY [J].
KUWABARA, Y ;
ICHIYA, Y ;
OTSUKA, M ;
MIYAKE, Y ;
GUNASEKERA, R ;
HASUO, K ;
MASUDA, K ;
TAKESHITA, I ;
FUKUI, H .
JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 1988, 12 (01) :47-48
[9]  
LARSON SM, 1981, J NUCL MED, V22, P875
[10]  
LESKINENKALLIO S, 1991, J NUCL MED, V32, P1211